Haemonetics (HAE) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $103.16 +0.23%
Revenue Growth %: +5.5%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.5%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39 million versus the consensus estimate of $302.62 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Explosions heard on Iran's Kharg island - MEHR
- CFRA Upgrades Qualcomm (QCOM) to Strong Buy
- monday.com Ltd. (MNDY) 5400 contracts of November 65 puts trade, share price down 6.6%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
